Item Type | Name |
Concept
|
Toxoplasma
|
Academic Article
|
Congenital toxoplasmosis transmitted from an immunologically competent mother infected before conception.
|
Academic Article
|
Measurement of the efficacy of vaccines and antimicrobial therapy against infection with Toxoplasma gondii.
|
Academic Article
|
HLA-class II genes modify outcome of Toxoplasma gondii infection.
|
Academic Article
|
Toxoplasma gondii tachyzoite-bradyzoite interconversion.
|
Academic Article
|
Growth of Toxoplasma gondii is inhibited by aryloxyphenoxypropionate herbicides targeting acetyl-CoA carboxylase.
|
Academic Article
|
Delivery of antimicrobials into parasites.
|
Academic Article
|
In vitro correlates of Ld-restricted resistance to toxoplasmic encephalitis and their critical dependence on parasite strain.
|
Academic Article
|
Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I.
|
Academic Article
|
Genetic analysis of influences on survival following Toxoplasma gondii infection.
|
Academic Article
|
Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening.
|
Academic Article
|
Evidence for mitochondrial-derived alternative oxidase in the apicomplexan parasite Cryptosporidium parvum: a potential anti-microbial agent target.
|
Academic Article
|
Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.
|
Academic Article
|
Expression, purification and preliminary crystallographic analysis of the Toxoplasma gondii enoyl reductase.
|
Academic Article
|
Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents.
|
Academic Article
|
Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life.
|
Academic Article
|
Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection.
|
Academic Article
|
Why prevent, diagnose and treat congenital toxoplasmosis?
|
Academic Article
|
Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans.
|
Academic Article
|
T. gondii RP promoters & knockdown reveal molecular pathways associated with proliferation and cell-cycle arrest.
|
Academic Article
|
Subcellular localization and dynamics of a digalactolipid-like epitope in Toxoplasma gondii.
|
Academic Article
|
NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells.
|
Academic Article
|
Identification of a sporozoite-specific antigen from Toxoplasma gondii.
|
Academic Article
|
Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America.
|
Academic Article
|
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo.
|
Academic Article
|
Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach.
|
Academic Article
|
P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages.
|
Academic Article
|
Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.
|
Academic Article
|
Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201.
|
Academic Article
|
Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009).
|
Academic Article
|
Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-? and reduces parasite burden in HLA-B*0702 mice.
|
Academic Article
|
Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections.
|
Academic Article
|
Effects of human class I transgenes on Toxoplasma gondii cyst formation.
|
Academic Article
|
Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8+T cell epitope based, adjuvanted vaccine protective against Toxoplasma gondii.
|
Academic Article
|
Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway.
|
Academic Article
|
Salicylanilide inhibitors of Toxoplasma gondii.
|
Academic Article
|
Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection.
|
Academic Article
|
Lipidomic analysis of Toxoplasma gondii reveals unusual polar lipids.
|
Academic Article
|
Immunogenetics of Toxoplasma gondii informs vaccine design.
|
Academic Article
|
Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants.
|
Academic Article
|
Oral oocyst-induced mouse model of toxoplasmosis: effect of infection with Toxoplasma gondii strains of different genotypes, dose, and mouse strains (transgenic, out-bred, in-bred) on pathogenesis and mortality.
|
Academic Article
|
Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii.
|
Academic Article
|
Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase.
|
Academic Article
|
Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.
|
Academic Article
|
Development of a triclosan scaffold which allows for adaptations on both the A- and B-ring for transport peptides.
|
Academic Article
|
Spiroindolone that inhibits PfATPase4 is a potent, cidal inhibitor of Toxoplasma gondii tachyzoites in vitro and in vivo.
|
Academic Article
|
The benzimidazole based drugs show good activity against T. gondii but poor activity against its proposed enoyl reductase enzyme target.
|
Academic Article
|
Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice.
|
Academic Article
|
Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.
|
Academic Article
|
Patterns of Hydrocephalus Caused by Congenital Toxoplasma gondii Infection Associate With Parasite Genetics.
|
Academic Article
|
Clustering of Toxoplasma gondii Infections Within Families of Congenitally Infected Infants.
|
Academic Article
|
Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove.
|
Academic Article
|
New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections.
|
Academic Article
|
Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii.
|
Academic Article
|
Seroprevalence of Toxoplasma gondii in domestic pets from metropolitan regions of Panama.
|
Academic Article
|
Prevalence and genetic characterization of Toxoplasma gondii in free-range chickens from grocery stores and farms in Maryland, Ohio and Massachusetts, USA.
|
Academic Article
|
Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries.
|
Academic Article
|
Global initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis.
|
Academic Article
|
Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer.
|
Academic Article
|
The zebrafish, Danio rerio, as a model for Toxoplasma gondii: an initial description of infection in fish.
|
Academic Article
|
Rapid, inexpensive, fingerstick, whole-blood, sensitive, specific, point-of-care test for anti-Toxoplasma antibodies.
|
Academic Article
|
Protein nanovaccine confers robust immunity against Toxoplasma.
|
Academic Article
|
CSGID Solves Structures and Identifies Phenotypes for Five Enzymes in Toxoplasma gondii.
|
Academic Article
|
Evaluation of Three Point-of-Care Tests for Detection of Toxoplasma Immunoglobulin IgG and IgM in the United States: Proof of Concept and Challenges.
|
Academic Article
|
Identification and development of novel inhibitors of Toxoplasma gondii enoyl reductase.
|
Grant
|
Multimodal Neuroimaging of Toxoplasma Infected Human Brain
|
Academic Article
|
Publisher Correction: Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer.
|
Academic Article
|
The One Health Approach to Toxoplasmosis: Epidemiology, Control, and Prevention Strategies.
|
Academic Article
|
Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites.
|
Academic Article
|
Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice.
|
Academic Article
|
High performance of a novel point-of-care blood test for Toxoplasma infection in women from diverse regions of Morocco.
|
Academic Article
|
Evaluation of the acceptability of point of care diagnostic test for prenatal toxoplasmosis (translational research phase III).
|
Grant
|
NOVEL APICOMPLEXAN METABOLISM AND ORGANELLE TRANSIT
|
Grant
|
FIFTH INTERNATIONAL TOXOPLASMA CONFERENCE (MAY 1999)
|
Grant
|
CTL IMMUNE RESPONSE TO INGESTED TOXOPLASMA
|
Grant
|
Treatment of Congenital Toxoplasmosis
|
Grant
|
Optimizing Inhibitors of T. gondii ENR
|
Academic Article
|
CD4+ T Cell Responses to Toxoplasma gondii Are a Double-Edged Sword.
|
Academic Article
|
Performances of ICT Toxoplasma IgG-IgM test in comparison with VidasĀ® toxo competition to determine the immune status against Toxoplasma gondii.
|
Academic Article
|
From TgO/GABA-AT, GABA, and T-263 Mutant to Conception of Toxoplasma.
|
Academic Article
|
Novel paradigm enables accurate monthly gestational screening to prevent congenital toxoplasmosis and more.
|
Academic Article
|
Impact of education on knowledge, attitudes, and practices for gestational toxoplasmosis.
|